GlassScriptPhysician profile
Robert J Starkenburg
NPI 1609878776
$2,812.63
in general payments reported to CMS, 2019-2025
35 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,366 · 2020: $416 · 2021: $30.75.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $343.34 | 2019-2020 | |
| Amgen INC. | $270.23 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $187.36 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $154.76 | 2019-2020 | |
| Lilly USA, LLC | $138.12 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $133.77 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $131.67 | 2019 | |
| Janssen Pharmaceuticals, INC | $130.29 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.91 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $118.84 | 2019-2020 | |
| Glaxosmithkline, LLC. | $110.64 | 2019-2020 | |
| Pfizer INC. | $95.40 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $90.13 | 2019 | |
| Arbor Pharmaceuticals, INC. | $74.39 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $74.06 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $72.21 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $67.65 | 2019-2020 | |
| Amarin Pharma, INC. | $62.19 | 2019 | |
| Scilex Pharmaceuticals INC. | $55.45 | 2019 | |
| Corcept Therapeutics | $46.55 | 2019 | |
| Acadia Pharmaceuticals INC | $39.84 | 2019-2020 | |
| Astellas Pharma US INC | $36.02 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $35.91 | 2019 | |
| Allergan, INC. | $34.21 | 2019-2020 | |
| Eisai INC. | $22.44 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $22.29 | 2019 | |
| Medline Industries LP | $19.19 | 2019 | |
| Abbvie INC. | $17.85 | 2021 | |
| Acorda Therapeutics, INC | $17.24 | 2019 | |
| Horizon Therapeutics Plc | $17.07 | 2019 | |
| Ironwood Pharmaceuticals, INC | $16.73 | 2020 | |
| Mylan Specialty L.P. | $14.88 | 2019 | |
| Sanofi Pasteur INC. | $14.73 | 2019 | |
| Boston Scientific Corporation | $14.64 | 2019 | |
| Therapeuticsmd, INC. | $12.63 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Starkenburg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.